Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Green Oasis Environmental, Inc. (GRNO) -- Ignore unavailable to you. Want to Upgrade?

To: Charles A. King who wrote (9192)	4/20/1998 10:25:00 AM
From: John Chylek	Read Replies (1) \| Respond to of 13091

OFF-TOPIC: Charles, about a year ago Barron's published a chart/article comparing the DJIA during the 1990s with the use of Prozac in the brokerage houses of Wall Street during the same period. The upward ticks are strikingly parallel. Barron's wasn't willing to postulate a theorem, but it would appear that as long as pharmacueticals are legal, and Wall Street is happily lobotomized, the DOW is okay. John

To: Charles A. King who wrote (9192)	4/20/1998 12:02:00 PM
From: Michael L. Voorhees	Read Replies (3) \| Respond to of 13091

Charles: thanks for the response. The only rebuttal I have is how will regulations change the drug situtation. They won't and never will. The only way to change it is to change the culture. Regulating things at the backend has never proved to be efficient and never will be. Changes during the process of life (i.e. culture) is the only way to make inroads, not the backend IMHO. Back to the GRNO topic: it seems that GRNO may well indeed be receiving treatment from the regulators which is in variance with the norm. The risks of this process to the environment are nill (we know, GRNO knows it, DHEC knows it, FEPA knows it, etc). May I say more, the regulatory process is broken and we are economic witnesses to that fact.